Consistent with the results of bioinformatics analysis, patients with high AFP level (Figure 5A), advanced tumor stage (Figure 5B), and poor tumor differentiation (Figure 5C) had lower CTC‐297N7.9 expression level in their tumor tissues. This evidence concerns the gene AFP and neoplasm.